RO6889450 (ralmitaront)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO6889450 (ralmitaront), covering 2023-10-10 to 2023-10-10. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 2]